Eastman Chem Co SEC Filings

Eastman Chemical (EMN) reported weaker Q3 2025 results. Sales were $2,202 million versus $2,464 million a year ago, and earnings before income taxes were $134 million versus $280 million. Net earnings were $47 million, with diluted EPS of $0.40 compared to $1.53.

Segment performance softened: total segment Adjusted EBIT was $249 million versus $407 million, with declines in Advanced Materials ($53 million vs $122 million), Chemical Intermediates ($1 million vs $43 million), and Fibers ($67 million vs $112 million). Additives & Functional Products was $128 million versus $130 million. The effective tax rate rose to 65%, reflecting impacts from the One Big Beautiful Bill Act and uncertain tax positions.

Year-to-date cash from operations was $468 million, capital expenditures $434 million, and net interest expense $156 million. Total borrowings were $5,075 million, including $290 million of commercial paper. Environmental reserves increased to $322 million. The company received $14 million of DOE reimbursements tied to a terminated grant related to the Longview, Texas recycling project.

Damon J. Audia, a director of Eastman Chemical Co. (EMN), reported crediting of 1,360 phantom stock units on 10/07/2025 under the Directors' Deferred Compensation Plan. The report shows two entries: 873 units credited at a market-linked value of $62.35 each and 487 units credited with a $0 price (automatic deferral), totaling 1,360 units beneficially owned following the transactions. These phantom units mirror the market value of one share each but are payable only in cash after the director's service ends, and thus do not represent actual shares with voting rights.

The Form 4 was filed as a single reporting person filing and signed by power of attorney on 10/09/2025. The entries reflect voluntary and automatic deferrals of director retainer fees into the director's deferred stock account rather than open-market purchases or option exercises.

Eastman Chemical (EMN) director Renee J. Hornbaker reported an automatic deferral under the Directors' Deferred Compensation Plan. On 10/07/2025, she was credited with 487 phantom stock units (value equal to one share of common stock), at a price of $0, reflecting a portion of her annual retainer fees. Phantom units are payable only in cash after service as a director ends.

Following the transaction, she beneficially owned 49,781 derivative securities. This total includes 1,151 units credited since April 7, 2025 as hypothetical reinvestment of dividend equivalents.

Eastman Chemical (EMN) director Linnie M. Haynesworth reported acquiring 487 Phantom Stock Units on 10/07/2025 at $0, reflecting an automatic deferral of a portion of her annual director retainer into the Directors' Deferred Compensation Plan. After the transaction, she beneficially owns 3,559 phantom units. Each unit has a value equal to one share of common stock and is payable only in cash after her service as a director ends. The total includes 42 units credited since May 1, 2025 as hypothetical reinvestment of dividend equivalents.

Director Eric L. Butler received 487 phantom stock units on 10/07/2025 under the Directors' Deferred Compensation Plan; each unit tracks one share of common stock and is payable in cash only after he leaves board service. Those units were credited via an automatic deferral of part of his annual retainer and include 53 units credited since 04/07/2025 as hypothetical reinvestment of dividend equivalents. After this transaction, Mr. Butler beneficially owns 2,768 shares (direct). The reported price per unit/share for the transaction is $0, reflecting an internal accounting credit rather than an open-market purchase. The filing was signed by a power of attorney on behalf of Mr. Butler on 10/09/2025.

Insider filing for Eastman Chemical Co. (EMN) reports that director Julie Fasone received 487 phantom stock units under the Directors' Deferred Compensation Plan on 10/07/2025. These units mirror the market value of one share each and are payable only in cash after she leaves board service. The filing shows 14,377 common-stock-equivalent units beneficially owned after the transaction, which includes 324 units credited since 04/07/2025 from reinvested dividend equivalents. The 487 units represent an automatic deferral of part of her annual retainer that would otherwise have been paid in cash. The filing was signed by a power of attorney on 10/09/2025.

James J. O'Brien, a director of Eastman Chemical Co. (EMN), acquired 487 phantom stock units under the company's Directors' Deferred Compensation Plan on 10/07/2025. These units are valued like common shares but are payable only in cash after he leaves board service. The report shows 17,407 shares (or equivalent units) beneficially owned following the transaction, which includes 395 additional units credited since 04/07/2025 from reinvested dividend equivalents. The 487 units arose from an automatic deferral of part of his annual retainer that would otherwise have been paid in cash; the per‑unit price for the phantom units is reported as $0 for administrative reporting purposes.

Eastman Chemical (EMN) director transaction: On 10/07/2025, a director acquired 487 phantom stock units under the Directors' Deferred Compensation Plan, recorded at $0 as an automatic deferral of a portion of annual retainer fees. Following this, the director beneficially owned 1,267 phantom stock units. These units track the value of common stock and are payable only in cash after the director’s service ends. The total includes 19 units credited since April 7, 2025 from dividend-equivalent reinvestments.